Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Nov 15, 2023; 15(11): 1891-1899
Published online Nov 15, 2023. doi: 10.4251/wjgo.v15.i11.1891
Published online Nov 15, 2023. doi: 10.4251/wjgo.v15.i11.1891
Study design | Number of MAP patients | Main findings | Ref. |
Cohort study | 394 | None of the four MAP-associated duodenal cancers (about 1%) reported in this cohort study developed in the context of prior stage IV disease. Three of them involved the distal duodenum | [11] |
Retrospective study | 92 | One duodenal and one ampullary cancer occurred in this cohort (about 2%), none in the context of prior stage IV disease | [9] |
European multicenter study | 276 | Duodenal polyposis occurred in 17% of patients who underwent esophagogastroduodenoscopy. SS classification was not presented. Two duodenal cancers were reported (about 1%) | [10] |
- Citation: Sanchez-Mete L, Mosciatti L, Casadio M, Vittori L, Martayan A, Stigliano V. MUTYH-associated polyposis: Is it time to change upper gastrointestinal surveillance? A single-center case series and a literature overview. World J Gastrointest Oncol 2023; 15(11): 1891-1899
- URL: https://www.wjgnet.com/1948-5204/full/v15/i11/1891.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i11.1891